Bruxism (teeth grinding) Treatment Market – Top Device Manufacturer Patterson Dental Supply, Randmark Dental Products and S4S Dental Laboratory – Strategies & Forecasts till 2023

“Sleeping Bruxism Treatment Market”
Market Research Future published a cooked research report on “Sleeping Bruxism Treatment Market Research Report – By Major Industry Trends, Worldwide Disease Analysis, Major Segments and Sub segments. Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Sleeping Bruxism Treatment Market – Overview

The global sleeping bruxism treatment market is expected to touch USD 638.22 million valuation by 2023, expanding at a modest CAGR of 6.7% during the forecast period (2018-2023), reports Market Research Future (MRFR). Sleeping bruxism is a disorder in which people grind or clench their teeth during sleep. This incident is quite natural. However, if the rate goes higher, it can damage the teeth or affect the jaw muscles.

According to a study published by Sleep Research Society (SRS), generally 5-8% people suffer from this disorder resulting in tooth wear and headaches which inadvertently distresses their lifestyle. This can give rise to preventive measures such as anti-depressants, mouth guard, muscle relaxants, and others and provide a favorable condition for the market.

Mayo Foundation’s report for the Medical Education and Research on sleeping bruxism reveals that the prevalence of bruxism among children varied from 3.5-40.6% and was seconded by the Journal of Conservative Dentistry. Both the reports suggested a hike in the number of affected children population. With the U.S. Census Bureau’s count of 74.7 million children by 2023, it has become even more disconcerting. This daunting number can drive the market further.  

However, there is no specific cure for sleeping bruxism.  The available medications have side-effects which destabilize the physiological system. This could impede the market growth during the forecast period.

Get Sample Report with Current Market Trend here

Sleeping Bruxism Treatment Market – Top Players

APAC market is growing bigger day by day. According to the World Dental Show in 2017, the Indian dental market is expected to witness a staggering CAGR of 16% by the end of 2018 and reach USD 242.81 million valuation. In Australia, as per the reports of Snore Australia, 9% of women and 25% of men suffer from obstructive sleep apnea. This could also open up the market for further possibilities and also could lure in international players.

  • Randmark Dental Products, LLC
  • S4S Dental Laboratory
  • Ipsen Biopharmaceuticals, Inc.
  • Pfizer Inc. Henry Schein, Inc.
  • Patterson Dental Supply, Inc.
  • Merz Pharma GmbH & Co.
  • KGaA,
  • Ivoclar Vivadent AG
  • Carestream Dental
  • Akervall Technologies Inc., and others.


Global Sleeping Bruxism Treatment Market– Regional Analysis

Geographically the market covers the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas dominated the market in 2017 by holding 39.1% of the market share. This is due to the rising cases of stress and anxiety related diseases among the populace. According to the American Sleep Association, 10% of the adults and 15% of the children are affected by the disease. Almost 8.3 million of the U.S. population are suffering from the disease as reported by the World Socialist Website in 2017. The market in the region, with an astounding 6.9% CAGR can reach USD 252.27 million by 2023.

Europe is the second largest market where as per the European Orthodontic Society in 2014-2015 sleeping bruxism was prevalent in 14 to 20% of children, 8 to 12% of teenagers and 3% of the adult population. Obstructive sleep apnea syndrome is also a significant factor in the growth of this market as according to the reports of the European Lung Foundation, 3-7% male and 2-5% female suffer from the disease.

APAC is expected to open up possibilities owing to its significant investment in healthcare, economic growth, large population base, and adoption of advanced healthcare technology. As per the reports of State of the World’s Children 2016, UNICEF, South Asia has 627 million children population, almost 36% of the total population and the number is on the rise giving the market a favorable condition. Also, bruxism and dental care related awareness are spreading rapidly in countries such as India, China, Japan and South Korea which can boost the market.

Avail Stunning Discount on Customize Reports –


Global Sleeping Bruxism Treatment Market – Segmentation

The global market for sleeping bruxism treatment can be segmented by type, diagnosis, treatment, cause, patient, and end-user.

By type, the market includes primary bruxism and secondary bruxism. Primary bruxism occurs without any medical condition, and mainly the clenching or grinding of teeth takes place. Currently, the predicted segment valuation is USD 168.74 million which it can achieve by 2023. Secondary bruxism is often triggered by neurological disorders or by psychoactive substance consumption. This segment accounted for 72.7 % of the global market share.

Diagnosis-wise segmentation includes clinical examination, electromyographic methods, polysomnography, x-ray, and others. The disorder is not life-threatening but can result in dental problems making its early diagnosis necessary.

Treatment-based segmentation includes dental approaches and medications. It’s not always necessary for children as they tend to outgrow it with age. However, severe cases demand treatment and the dental approaches segment could reach up to a significant valuation during the forecast period. Dental medication commanded around 68.6% of the global market in 2017.

Based on cause, the market comprises obstructive sleep apnea, sleep paralysis, gastroesophageal reflux disease (GERD), malocclusion, and others. Reports of National Sleep Foundation reveals that one in four people suffer from obstructive sleep apnea which gives rise to sleeping bruxism. The market for obstructive sleep apnea is projected to reach USD 233.20 million at a 7% CAGR during the review period.

Based on patient type, the market is segmented into pediatric and adult. According to KidsHealth, 3 out of 10 children suffer from bruxism. Pediatric segment currently dominates the market with 68.5% of the global share in 2017 and in the foreseeable future, is expected to do so by reaching USD 440.28 million mark with a CAGR of 6.8% during the prognosis period.

The end-user segment includes hospitals, dental clinics, and others. With considerable technological advancements, hospitals and clinics now have ample provisions to take care of the situation. As the frontrunner, hospitals and clinics are projected to reach USD 270.50 million valuation during the review period.

 Analysis Period:

  • Base Year – 2017
  • Projection Period – From 2018 to 2023
  • Market Denomination – USD Million
  • Conversion Rate – Considered as per the respective financial years

Treatment Type:

  • Dental Approaches
    • Nociceptive Trigeminal Inhibition Tension Suppression System (NTI-tss) device
    • Mouth Guard
  • Medication
    • Anti-anxiety Drugs
    • Muscle Relaxants
    • Botox Injections


  • Obstructive Sleep Apnea
  • Sleep Paralysis
  • Malocclusion
  • Gastroesophageal reflux disease (GERD)


Get Full TOC Here

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India